In this webinar, Dr. Jihye Jo introduces PPI (protein-protein interaction) Landscape, powered by PROTEINA’s single-molecule SPID platform.

PPI Landscape transforms antibody libraries into sequence-to-affinity heatmaps, capturing 5,000 KD-precision data points per run with SPR/BLI-equivalent accuracy. Within just two weeks, the platform completes the entire workflow—from DNA library synthesis to mammalian (HEK/CHO) expression and single-molecule KD measurement—all without purification.

This quantitative Deep Mutational Scanning (qDMS) approach reveals how every mutation within the antibody CDRs affects binding affinity, guiding combinatorial library design across inter- and intra-CDR regions.

As a data-driven, high-throughput, fee-for-service solution, PPI Landscape enables rapid affinity maturation and tuning, delivering optimized antibody sequences with sub-nanomolar to picomolar affinities—at unmatched speed, scale, and precision.

Key Topics Include:

  • Discover how the PPI Landscape platform transforms antibody libraries into sequence-to-affinity heatmaps using single-molecule SPID technology.
  • Learn how 5,000 KD-precision data points per run enable high-throughput, quantitative Deep Mutational Scanning (qDMS) of antibody CDRs.
  • Explore how inter- and intra-CDR combinatorial libraries can be rationally designed from quantitative affinity landscapes.
  • Understand how this purification-free, mammalian-based workflow achieves SPR/BLI-equivalent accuracy with a two-week turnaround.
  • Gain insight into applying PPI Landscape data for affinity maturation, affinity tuning, and AI-assisted antibody optimization.

Presenters

Director
High-Throughput Antibody Engineering Platform
PROTEINA

Dr. Jihye Jo is Director of the High-Throughput Antibody Engineering Platform at PROTEINA, where she leads the development of SPID, a single-molecule fluorescence imaging technology that enables high-throughput antibody characterization and AI-driven antibody design.

Production Partner

PROTEINA

PROTEINA (KOSDAQ: 468530) is a biotechnology company redefining antibody engineering through single-molecule precision. Its proprietary SPID (Single-molecule Protein-Protein Interaction Detection) platform enables high-throughput, quantitative analysis of complex protein interactions at molecular resolution.

Additional Content From Scientist.com

Related Content